InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,012.73
(
0.35%
)
Post# of 13898
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Iam_in

Send PM Follow Ignore
Followers 2
Posts 266
Boards Moderated 0
Alias Born 08/12/2016

Iam_in

Re: None

Wednesday, 07/05/2017 4:18:56 AM

Wednesday, July 05, 2017 4:18:56 AM

Post# of 13898
NEWS OUT - NEWS OUT

Immune Pharmaceuticals' Oncology Subsidiary, Cytovia, Announces Addl. Clinical Trial Results on the Efficacy of Ceplene® in Combination Low-Dose IL-2 in Patients With Acute Myeloid Leukemia, Recently Published in Leukemia, a Leading Hematology Journal

...

complete:

https://www.bequoted.com/bolag/immune-pharmaceuticals/pressmeddelande/immune-pharmaceuticals-oncology-subsidiary-cytovia-announces-59532
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up